Gestalt and DLS Pathology Services Join Forces to Expand Digital Pathology Solutions Globally
In a significant move to enhance its global presence, Gestalt, an industry leader in AI-powered digital pathology solutions, has entered into a reseller agreement with DLS Pathology Services. This partnership will enable Gestalt to provide its esteemed digital platform directly to pathologists and healthcare organizations across Australia and other regions, marking a pivotal step in its international expansion strategy.
The Collaboration
This agreement allows DLS Pathology Services to utilize its local expertise and knowledge to facilitate the sales and support of Gestalt's highly regarded digital pathology capabilities. By leveraging their regional insights, DLS will ensure that pathologists can effectively utilize Gestalt's innovative digital solutions to enhance their consultative services in pathology.
Lisa-Jean Clifford, Chief Operating Officer and Chief Strategy Officer at Gestalt, expressed her enthusiasm about this collaboration. She stated, “We are thrilled to partner with DLS Pathology Services, allowing us to extend our cutting-edge digital pathology solutions to a broader global audience. This partnership blends our technological innovations with DLS’s deep understanding of local markets, ensuring pathologists in Australia and beyond can deliver outstanding diagnostic services.”
Dr. Jeremy Parry, Director of DLS Pathology Services, echoed these sentiments, emphasizing the advantages of Gestalt’s digital pathology platform. “Gestalt provides an exceptional platform for digital pathology services. Its capability to host and stream DICOM images efficiently, combined with a user-friendly interface, allows us to cater to clients regardless of their scale. After over ten years in the digital pathology sector, I can confidently say that Gestalt surpasses all Cloud platforms I have encountered in terms of speed and usability,” he remarked.
Innovative Solutions Offered
Gestalt Diagnostics specializes in transforming the field of pathology with a versatile, AI-driven digital workflow designed to foster true interoperability. The PathFlow solution, which includes modules for professional education and research, empowers pathologists to break free from mundane and repetitive tasks, allowing them to concentrate on what truly matters—delivering expert diagnosis.
The company’s approach not only improves efficiency but also ensures pathologists can tackle increasing workloads without compromising on quality. As the medical field rapidly evolves towards digital integration, partnerships like the one between Gestalt and DLS are essential to keeping up with technological advancements and growing healthcare needs.
Upcoming Events and Demonstrations
Healthcare professionals interested in exploring this partnership and the associated solutions can visit Gestalt at booth #934 during the USCAP event from March 23-26, 2025. Here, attendees will have the opportunity to see firsthand how Gestalt's innovative solutions can transform their digital pathology practices.
About Gestalt
Gestalt Diagnostics aims to revolutionize the pathology landscape through intelligent and configurable solutions that remain vendor-neutral. By offering a seamless experience, the company empowers pathologists to diagnose diseases more efficiently, ultimately enhancing patient care. For further information, visit
Gestalt’s website or follow them on LinkedIn @Gestalt.
About DLS Pathology Services
DLS Pathology Services is dedicated to nurturing and enhancing local pathology services irrespective of budget constraints or geographical barriers. With advancements in digital technology, no pathology service should be limited by logistical issues or traditional methodologies. DLS—standing for Deep Learning Solutions—focuses on leveraging deep learning technology and machine applications to fortify client services and support community healthcare needs.